The Short Answer
This page lists the liver transplant & hpb hospitals in our directory offering Pulmonary Fibrosis in UAE, including Burjeel Hospital for Advanced Surgery Dubai, Kings College Hospital Dubai, Aster Hospital Dubai. Each listing links through to the hospital's full profile page.
Ask us about pulmonary fibrosis in UAE
Share a few details and our care coordination team will get back to you with next steps.
Top Hospitals for Pulmonary Fibrosis in UAE
🇦🇪 Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE 4.5 (1 reviews) 209 beds
Why consider this hospital?
4.5/5 rating from 1 reviews209 beds
Specialties & Accreditation
OrthopedicsCardiac SciencesCosmetic SurgeryGastroenterologyGeneral SurgeryGynecology
Hospit — Hospital Certificates of Services accreditation
View full profile →Patients considering pulmonary fibrosis can be cared for by Burjeel Hospital for Advanced Surgery Dubai's care team in Dubai, UAE, from initial consultation through recovery. Burjeel Hospital for Advanced Surgery Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.5/5
Rating
2014
Established
209
Beds
Dubai, UAE
Location
🇦🇪 Kings College Hospital Dubai
Dubai, UAE 4.5 (1 reviews) 100 beds
Why consider this hospital?
4.5/5 rating from 1 reviews100 beds
Specialties & Accreditation
Cardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral SurgeryGynecology
Hospit — Hospital Certificates of Services accreditation
View full profile →Patients considering pulmonary fibrosis can be cared for by Kings College Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Kings College Hospital Dubai, accredited by Hospital Certificates of Services, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.5/5
Rating
2014
Established
100
Beds
Dubai, UAE
Location
🇦🇪 Aster Hospital Dubai
Dubai, UAE 4.5 (1 reviews) 114 beds
Why consider this hospital?
4.5/5 rating from 1 reviews114 beds
Specialties & Accreditation
BariatricCardiac SciencesCosmetic SurgeryENTGastroenterologyGeneral Surgery
JCI — Joint Commission International accreditation
View full profile →Patients considering pulmonary fibrosis can be cared for by Aster Hospital Dubai's care team in Dubai, UAE, from initial consultation through recovery. Aster Hospital Dubai, accredited by JCI, follows recognised patient-safety and quality-of-care standards when performing pulmonary fibrosis.
4.5/5
Rating
1987
Established
114
Beds
Dubai, UAE
Location
Top Liver Transplant & HPB Doctors in UAE
FeaturedDr. Parthi Srinivasan
MBBS, FRCS, FRCS (General Surgery), CCST (Completion of Specialist Training)
Consultant — Liver Transplant & HPB Surgery · Specialty: Liver Transplant & HPB Surgery
Burjeel Medical City, Abu Dhabi Abu Dhabi, UAE30+ Years experience
Why consider this doctor?
- 30+ years of experience in Liver Transplant & HPB Surgery
- Consultant Surgeon — Liver Transplant & HPB Surgery, Burjeel Medical City, Abu Dhabi, UAE
- Clinical Lead — HPB Surgery, Living Donor Liver Transplantation, Islet Cell Transplantation & Organ Utilisation, King's College Hospital, London
Expertise & Procedures
- Cadaveric (deceased donor) liver transplantation
- Adult-to-adult living donor liver transplantation (right and left lobe)
- Liver re-transplantation
- Pancreatic islet cell transplantation
- Hepatic resection — right and left hepatectomy, extended resections
Liver Transplant & HPB Surgery Experience: 30+ YearsHospital Affiliation: Burjeel Medical City, Abu Dhabi
Dr. Nesrine Ahmed Elbioky
MBBS, Masters in Pediatric Hepatology
Specialist Pediatrics · Specialty: Liver Transplant & HPB
Burjeel Medical City, Abu Dhabi Abu Dhabi, UAE6+ Years experience
Why consider this doctor?
- 6+ years of experience in Liver Transplant & HPB
- Assistant Lecturer at Menoufia University, Egypt
Expertise & Procedures
- Lumbar puncture
- Gastric lavage
- Catheterizations
- Simple airway management
- Advanced airway management
Liver Transplant & HPB Experience: 6+ YearsHospital Affiliation: Burjeel Medical City, Abu Dhabi
Our Methodology
How we selected these hospitals
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
What To Look For
How to Select the Best Hospital for Pulmonary Fibrosis in UAE?
Choosing the right hospital for pulmonary fibrosis is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include liver transplant & hpb rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Clinical Overview
Understanding Pulmonary Fibrosis
Pulmonary fibrosis treatment in India and the UAE offers internationally accredited antifibrotic therapy, multidisciplinary ILD (interstitial lung disease) programs, and comprehensive lung transplant evaluation — at a fraction of Western costs.
5–10 days (initial evaluation and stabilization); 14–21 days (if lung transplant is performed)
Hospital Stay
2–4 weeks for antifibrotic therapy initiation and stabilization; 8–12 weeks minimum post-lung transplant before intercontinental flight clearance
Total Stay in Country (Fit-to-Fly)
60–75% disease stabilization on antifibrotic therapy; 85–90% 1-year post-transplant survival at high-volume centers
Success Rate
Clinical Overview
- Pulmonary fibrosis — most critically in its idiopathic form (IPF) — is a progressive, irreversible scarring of lung parenchyma driven by aberrant epithelial injury-repair cycles, fibroblast proliferation, and excess extracellular matrix deposition.
- As fibrosis advances, alveolar architecture is destroyed, gas exchange efficiency falls, and patients develop exertional hypoxemia, a dry non-productive cough, and progressively restrictive ventilatory physiology.
- Median survival from diagnosis without treatment is historically 3–5 years, though disease trajectory varies considerably — a minority follow a slowly progressive course, while others experience acute exacerbations that carry a 50–80% in-hospital mortality.
Who is a Candidate?
- CONFIRMED IPF DIAGNOSIS: Multidisciplinary ILD board consensus based on HRCT UIP pattern (± surgical lung biopsy via VATS) after exclusion of secondary causes (connective tissue disease, drug toxicity, hypersensitivity pneumonitis)
- ANTIFIBROTIC THERAPY CANDIDATES: FVC ≥50% predicted, DLCO ≥30% predicted, confirmed UIP/probable UIP on HRCT, NYHA/MRC dyspnea grade II–III, absence of advanced hepatic impairment (nintedanib) or severe photosensitivity contraindication (pirfenidone)
- TRANSPLANT EVALUATION CANDIDATES: Progressive disease despite ≥6 months of antifibrotic therapy, FVC <80% predicted with ≥10% relative decline over 12 months, DLCO <40% predicted, 6-minute walk test desaturation below SpO₂ 88%, or acute exacerbation requiring hospitalization
- REQUIRED DIAGNOSTIC WORKUP BEFORE TRAVEL: HRCT chest (thin-slice ≤1.5 mm), full pulmonary function tests (spirometry, plethysmography, DLCO), 6-minute walk test with oximetry, echocardiography (to assess pulmonary hypertension — a key modifier of transplant candidacy), CT pulmonary angiography or V/Q scan (to exclude chronic thromboembolic disease), standard metabolic panel, LFTs, renal function, and ANA/RF/anti-CCP/anti-Scl70 autoimmune panel
- +3 more
Treatment Options & Approaches
- ANTIFIBROTIC PHARMACOTHERAPY Nintedanib (Ofev®): A triple tyrosine kinase inhibitor administered orally at 150 mg twice daily with food.
- It inhibits PDGFR-α/β, FGFR-1/2/3, and VEGFR-1/2/3 — receptors that mediate fibroblast proliferation, differentiation, and migration.
- In the INPULSIS trials, nintedanib reduced annual FVC decline by 50% (approximately 50 mL/year vs. 200 mL/year on placebo).
Recovery
- PHASE 1 — PRE-ARRIVAL COORDINATION (2–4 weeks before travel) GAF Healthcare's medical coordinators review all existing diagnostic records (HRCT, PFTs, bronchoscopy/biopsy reports, echocardiography) via a secure digital portal.
- The in-house medical team prepares a provisional treatment pathway — antifibrotic initiation vs. transplant evaluation — and selects the appropriate partner center.
- The patient receives a pre-travel checklist specifying required investigations to be completed at home to avoid duplication and unnecessary cost. e-Medical visa (India) or UAE entry visa documentation is prepared in parallel.
Risks to be aware of
- Pulmonary fibrosis treatment carries a distinct risk profile at each stage of the care pathway, and patients must receive a fully transparent risk discussion before travel.
Why GAF Healthcare
- GAF Healthcare provides an integrated medical tourism support infrastructure that addresses every non-clinical barrier to treatment access for international patients.
Common questions about Pulmonary Fibrosis
What is the cost of Pulmonary Fibrosis Treatment (Antifibrotic Therapy & Transplant Evaluation) in India vs. the UAE?
The total cost depends on the specific treatment pathway — antifibrotic therapy initiation with full ILD workup, or lung transplant evaluation and transplantation.
In India, the cost for a comprehensive ILD workup and antifibrotic therapy initiation (including hospital admission, all diagnostics — HRCT, PFTs, echocardiography, right heart catheterization where indicated — pulmonary rehabilitation, and 2-week supervised medication titration) ranges from USD 3,500 to USD 8,000. A full bilateral lung transplant in India, including pre-transplant evaluation, surgery, ICU care, and 3-week hospitalization, typically costs USD 28,000 to USD 45,000 all-inclusive.
In the UAE (Dubai/Abu Dhabi), equivalent ILD workup and antifibrotic initiation costs range from USD 7,000 to USD 15,000, while a bilateral lung transplant ranges from USD 55,000 to USD 90,000, reflecting the premium infrastructure, nursing ratios, and luxury accommodation standards of UAE hospitals.
India is typically 40–60% less expensive than the UAE across all stages of care. Both destinations offer care at JCI-accredited hospitals (India additionally with NABH accreditation; UAE with DHA/MOH regulatory oversight), ensuring clinical quality comparable to Western European or North American centers. GAF Healthcare provides transparent, itemized cost estimates before any commitment is made.
How long do I need to stay in India or the UAE before I am fit to fly home?
The required in-country stay depends on your treatment pathway:
ANTIFIBROTIC THERAPY INITIATION: Most patients require 2–4 weeks in-country. The first 3 days are for diagnostic confirmation and MDT review, followed by 10–14 days of supervised medication titration to confirm tolerability (GI side effects for both nintedanib and pirfenidone typically peak and stabilize within the first 2 weeks). A fit-to-fly assessment at Day 14–21 evaluates SpO₂ stability at rest and on ambulation, treatment tolerance, and confirms that the patient has access to ongoing antifibrotic prescriptions and a pulmonologist in their home country. Most patients with stable disease at this point can fly safely in standard commercial class with or without ambulatory oxygen, depending on their baseline DLCO and resting SpO₂.
LUNG TRANSPLANT EVALUATION ONLY (NO TRANSPLANT PERFORMED): 2–3 weeks for the complete organ-system workup, MDT listing conference, and listing decision. Most patients are medically stable enough to fly home within 3–4 weeks pending no acute deterioration during evaluation.
BILATERAL LUNG TRANSPLANTATION: Minimum in-country stay is 8–10 weeks post-surgery. The first 3–4 weeks are spent as an inpatient (ICU followed by step-down ward). After hospital discharge, outpatient visits continue weekly for the next 4–6 weeks for immunosuppression monitoring, surveillance bronchoscopy (at 4–6 weeks), and spirometry. Intercontinental flights (>8 hours) are generally cleared at 8–10 weeks post-transplant, contingent on stable graft function, no active rejection or infection, independence from supplemental oxygen at rest, and a confirmed post-transplant follow-up plan with a pulmonologist in the home country. GAF Healthcare provides the treating airline with a standard medically fit-to-fly certificate signed by the transplant team.
What is the success rate of Pulmonary Fibrosis Treatment in India and the UAE?
Success in pulmonary fibrosis treatment is defined differently at each stage of the care pathway, and it is important for patients to have realistic, evidence-based expectations.
ANTIFIBROTIC THERAPY: Both approved antifibrotic agents (nintedanib and pirfenidone) reduce the annual rate of FVC decline by approximately 50% compared to the natural disease course. In clinical terms, approximately 60–75% of appropriately selected patients achieve disease stabilization (defined as <10% relative FVC decline over 12 months) in the first year of treatment. Neither agent reverses existing fibrosis or improves lung function; the goal is slowing progression and reducing the risk and frequency of acute exacerbations. GAF Healthcare partner centers achieve these outcomes through rigorous patient selection, structured tolerability management (dose optimization rather than premature discontinuation), and integration of pulmonary rehabilitation, which independently improves functional capacity and quality of life.
LUNG TRANSPLANTATION: At high-volume centers in India and the UAE — defined as centers performing ≥20 lung transplants per year with established ISHLT registry participation — outcomes closely parallel international benchmarks. The 1-year post-lung transplant survival rate is 85–90%, the 3-year survival is approximately 70–75%, and the 5-year survival is 55–65% for IPF recipients. Bilateral sequential lung transplantation (the preferred procedure for IPF) confers a meaningful survival advantage over single-lung transplantation. The primary determinants of outcome are center volume and experience, surgical technique, primary graft dysfunction prevention (optimal organ preservation and ischemic time minimization), and the quality of post-transplant immunosuppression management and infection surveillance — all of which are rigorously standardized at GAF Healthcare's partner transplant centers.
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Pulmonary Fibrosis in UAE
Discover the Top Hospitals for Pulmonary Fibrosis in UAE
This page lists 3 accredited liver transplant & hpb hospitals in UAE, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Patient Success Story
Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions
Frequently asked questions about pulmonary fibrosis in UAE
How many liver transplant & hpb hospitals are listed in UAE?
3 hospitals in our UAE directory are currently listed for liver transplant & hpb including Pulmonary Fibrosis.
How do you choose which hospitals to list?
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in UAE. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in UAE?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Which cities in UAE have liver transplant & hpb hospitals listed?
Dubai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including Hospital Certificates of Services, JCI — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for pulmonary fibrosis?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for pulmonary fibrosis in UAE.
Contact us to report an inaccuracy on this page.